| Secondary |
| Drug Use For Unknown Indication |
28.2% |
| Product Used For Unknown Indication |
25.2% |
| Neuralgia |
7.4% |
| Back Pain |
6.7% |
| Hypertension |
3.7% |
| Pyrexia |
3.1% |
| Breast Cancer |
2.5% |
| Intentional Overdose |
2.5% |
| Restless Legs Syndrome |
2.5% |
| Toothache |
2.5% |
| Analgesic Therapy |
1.8% |
| Anxiety |
1.8% |
| Depression |
1.8% |
| Hepatitis C |
1.8% |
| Hepatitis C Virus Test Positive |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Acute Sinusitis |
1.2% |
| Atrial Fibrillation |
1.2% |
| Dyslipidaemia |
1.2% |
| Nausea |
1.2% |
|
| Nausea |
20.0% |
| Vomiting |
12.5% |
| Pancreatitis Acute |
7.5% |
| Respiratory Acidosis |
7.5% |
| Pulmonary Embolism |
5.0% |
| Respiratory Distress |
5.0% |
| Somnolence |
5.0% |
| Urinary Tract Infection |
5.0% |
| Wound |
5.0% |
| Aphthous Stomatitis |
2.5% |
| Cholestasis |
2.5% |
| Cholestatic Liver Injury |
2.5% |
| Diarrhoea Haemorrhagic |
2.5% |
| Drug Level Increased |
2.5% |
| Gastrointestinal Haemorrhage |
2.5% |
| Interstitial Lung Disease |
2.5% |
| Irritability |
2.5% |
| Macrocytosis |
2.5% |
| Malaise |
2.5% |
| Mixed Liver Injury |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.2% |
| Product Used For Unknown Indication |
10.8% |
| Hypertension |
10.4% |
| Pain |
8.0% |
| Rheumatoid Arthritis |
6.3% |
| Constipation |
5.1% |
| Breast Cancer |
3.9% |
| Abdominal Pain |
3.4% |
| Anxiety |
3.4% |
| Back Pain |
2.9% |
| Heart Transplant |
2.9% |
| Multiple Myeloma |
2.9% |
| Depression |
2.7% |
| Insomnia |
2.7% |
| Prophylaxis |
2.7% |
| Bone Pain |
2.4% |
| Atrial Flutter |
2.2% |
| Essential Hypertension |
2.2% |
| Prostate Cancer |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
|
| Vomiting |
17.3% |
| Renal Failure |
8.0% |
| Thrombocytopenia |
8.0% |
| Jaundice |
5.3% |
| Nausea |
5.3% |
| Neutropenia |
5.3% |
| Renal Failure Acute |
5.3% |
| Transaminases Increased |
5.3% |
| Paraesthesia |
4.0% |
| Pulmonary Embolism |
4.0% |
| Rhabdomyolysis |
4.0% |
| Suicidal Ideation |
4.0% |
| Walking Aid User |
4.0% |
| Weight Decreased |
4.0% |
| Acute Myeloid Leukaemia |
2.7% |
| Cutaneous Vasculitis |
2.7% |
| Emphysema |
2.7% |
| Haemoptysis |
2.7% |
| Meningococcal Sepsis |
2.7% |
| Myalgia |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
85.7% |
| Pain |
14.3% |
|
| Respiratory Distress |
100.0% |
|
